Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Apnea, Obstructive 1 Lymphoma, Follicular 1

Interventions

Rituximab 16 Cyclophosphamide 12 fludarabine phosphate 8 Peripheral Blood Stem Cell Transplantation 7 Vincristine 5 Radiotherapy 5 Prednisone 5 Lenalidomide 5 Etoposide 5 Doxorubicin 5 Cytarabine 5 Bendamustine Hydrochloride 5 fludarabine 4 Whole-Body Irradiation 4 Filgrastim 4 tazemetostat 3 Mycophenolic Acid 3 Melphalan 3 Carmustine 3 umbralisib 2 ublituximab 2 sargramostim 2 parsaclisib 2 ofatumumab 2 ibritumomab tiuxetan 2 duvelisib 2 Tacrolimus 2 Pentostatin 2 Pentetic Acid 2 Methotrexate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lymphoma, Follicular × Mometasone Furoate × Clear all

NCT01671852 2015-07-30

Nasonex OSA

Children's & Women's Health Centre of British Columbia

Phase 3 Withdrawn

Lymphoma, Follicular, Sleep Apnea, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡